Caleres (CAL) Q2 2026 Earnings Call Transcript

Caleres reported Q2 sales of $695.5 million, up 5.6%, and adjusted diluted EPS of $0.47 versus $0.35 a year earlier, supported by a 340bp gross-margin expansion to 46.8%. Brand Portfolio sales rose 23.6% (8.2% organically), while Famous Footwear sales fell 6.3% amid delayed back-to-school demand and lifestyle-athletic weakness; Famous comparable sales were flat through Labor Day after a 5.9% Q2 decline. Management raised the low end of FY2026 adjusted EPS guidance to $1.50-$1.65 from $1.40, but continues to expect low-to-mid-single-digit Famous sales declines, promotional pressure, and an uncertain tariff environment.

Analysis

CAL's investable issue is now a mix shift, not a top-line recovery: high-margin owned brands and wholesale are absorbing the earnings burden while Famous Footwear is becoming a lower-return traffic and inventory-clearing channel. The brand portfolio's margin profile creates meaningful operating leverage if fashion demand persists, but the acquisition introduces execution risk because Stuart Weitzman's targeted breakeven still contributes no incremental operating profit despite consuming capital, management bandwidth and working capital. The balance-sheet headroom is adequate, yet revolver-funded inventory and a $16-$17M annual interest burden limit tolerance for another markdown cycle.

Over the next 1-3 months, the critical read-through is whether fashion footwear can convert early demand into full-price fall/holiday sell-through before weather-sensitive boot receipts arrive. A sustained category rotation is incrementally favorable to CAL relative to NKE, whose lifestyle franchise remains more exposed to legacy-silhouette normalization, and to SHOO, which competes for similar fashion dollars but lacks CAL's captive family-retail distribution. BIRK remains a beneficiary of premium comfort demand, though its wholesale success could also pressure CAL's Famous margin if premium brand vendors retain pricing power.

Consensus may over-credit the raised EPS floor: it was aided by non-operating interest/tax assumptions while the upper end was unchanged, implying management has not gained confidence in the core retail turnaround. The more constructive contrarian case is that Famous' markdowns are deliberately pulling forward pain; if inventory clears without incremental comp deterioration, even modest stabilization can sharply improve consolidated earnings because the brand portfolio is already demonstrating margin scalability. Falsification: Famous comps remain down mid-single digits through holiday, gross-margin pressure exceeds roughly 100 bps year-over-year, or Stuart Weitzman misses its 2026 breakeven target.

Structural upside over 6-18 months depends on international expansion and whether Caleres can monetize brand relevance through wholesale without recreating promotional dependency. International is still too small to offset a prolonged domestic retail decline, so investors should demand evidence of profitable—not merely rapid—growth: stable wholesale returns/allowances, sustained full-price sell-through, and declining revolver utilization after seasonal inventory peaks.

Key Decisions for Investors

• Initiate a small tactical long CAL ahead of holiday footwear sell-through data; target a 15-20% upside over 3-6 months if Famous comps stabilize near flat and brand-portfolio margins hold. Use a stop/reassess trigger on a holiday comp decline worse than 5% or evidence that Famous markdown pressure accelerates.
• Express the category rotation as long CAL / short NKE on a 3-6 month horizon, sized beta-neutral. CAL has increasing fashion exposure while NKE remains more vulnerable to lifestyle-athletic normalization; exit if NKE demonstrates broad lifestyle sell-through recovery or CAL's Famous margin deteriorates beyond management's indicated run rate.
• Do not underwrite Stuart Weitzman as an earnings contributor until the next report confirms progress toward breakeven through full-price sales and lower operating losses. Treat a miss versus the 2026 breakeven objective as a catalyst to reduce CAL exposure, given the acquisition's inventory and fixed-cost burden.
• Monitor BIRK as a supplier/competitive indicator rather than a direct CAL proxy: continued premium-comfort strength supports Famous traffic, but accelerating vendor pricing or weaker wholesale availability would worsen Famous gross margin. Add CAL only if premium-product penetration rises without a corresponding decline in gross margin.